Alere: Alere agrees to $20m settlement in investor suit

Abbott's (NYSE:ABT) Alere (NYSE:ALR) has agreed to pay $20 million to settle an investor's suit claiming it made misleading statements about its blood diagnostics business shortly before its proposed billion-dollar merger with Abbott, according to recently released court documents. The suit was originally filed in 2016 by Judith Godinez in the U.S. District Court for the District [...]The post Alere agrees to $20m settlement in investor suit appeared first on MassDevice.